Phase 2, placebo-controlled clinical study of oral ganaxolone in PCDH19-clustering epilepsy. Sullivan J, Gunning B, Zafar M, Guerrini R, et al. Epilepsy Res 2023;191:107112.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sullivan J, Gunning B, Zafar M, Guerrini R, et al. Phase 2, placebo-controlled clinical study of oral ganaxolone in PCDH19-clustering epilepsy. Epilepsy Res 2023;191:107112.
PMID: 36870093